Difference between revisions of "Key-Gaskell Syndrome"
JamesSwann (talk | contribs) |
JamesSwann (talk | contribs) |
||
| Line 3: | Line 3: | ||
{| cellpadding="10" cellspacing="0" border="1" | {| cellpadding="10" cellspacing="0" border="1" | ||
| Also known as: | | Also known as: | ||
| − | | '''Autonomic | + | | '''Autonomic Polyganglioneuropathy'''<br> |
'''Feline Dysautonomia''' | '''Feline Dysautonomia''' | ||
|} | |} | ||
| Line 38: | Line 38: | ||
===Pharmalogical Tests=== | ===Pharmalogical Tests=== | ||
| − | * Topical ocular administration of dilute pilocarpine | + | Various provocative tests can be used to assess the autonomic nerbous systems of animals with suspected Key-Gaskell syndrome: |
| − | * | + | *Topical ocular administration of dilute pilocarpine should result in miosis, which implies a postive result. However, not all animals respond and the response is dependent on the degree of damage to the postganglionic parasympathetic neuron causing (denervation) supersensitivity of the iris muscle. |
| − | * | + | *Intra-venous or subcutaneous administration of atropine (a parasympatholytic) should result in an increase in the heart rate. A failure to respond implies a positive result. |
| + | *Intra-dermal administration of histamine should result in a classical wheal and flare response but this may be dampened in those animals with dysautonomia. An absence of the wheal and flare response is therefore a positive result. | ||
=====Pathology===== | =====Pathology===== | ||
[[Image:Ba 250 07.jpg|thumb|Histological section of a degenerate neuron from a cat with Key-Gaskell Syndrome<br><small>Copyright Susan Rhind 2007 RVC]]</small> | [[Image:Ba 250 07.jpg|thumb|Histological section of a degenerate neuron from a cat with Key-Gaskell Syndrome<br><small>Copyright Susan Rhind 2007 RVC]]</small> | ||
| − | *Histologically there is marked reduction in the number of neurones in all autonomic ganglia in the ventral horn of all levels of spinal cord accompanied by proliferation of non-neuronal cells. | + | *Histologically there is marked reduction in the number of neurones in all autonomic ganglia in the ventral horn of all levels of spinal cord accompanied by proliferation of non-neuronal cells. Similar changes are found in the brainstem nuclei of the cranial nerves and features of chromatolytic degeneration may be apparent in the ganglia, spinal cord and sympathetic axons. |
| − | |||
| − | |||
| − | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| − | There are few | + | There are few differential diagnoses for this clinical presentation but, early in the course of disease, other causes of [[Megaoesophagus|megaoesophagus]] should be considered. |
| − | |||
==Treatment== | ==Treatment== | ||
| Line 58: | Line 55: | ||
===Parasympathomimetic Drugs=== | ===Parasympathomimetic Drugs=== | ||
Some dogs may show minor improvement on initiation of for example, bethanechol, metoclopramide. | Some dogs may show minor improvement on initiation of for example, bethanechol, metoclopramide. | ||
| − | |||
==Prognosis== | ==Prognosis== | ||
Guarded to poor. Recovery rates in the cat are reported as 20-40%, however this may take 2-12 months. In the dog recovery rates are lower. Despite recovery many are also left with residual impairment including intermittent regurgitation. | Guarded to poor. Recovery rates in the cat are reported as 20-40%, however this may take 2-12 months. In the dog recovery rates are lower. Despite recovery many are also left with residual impairment including intermittent regurgitation. | ||
| − | |||
==References== | ==References== | ||
Revision as of 16:16, 30 July 2010
 |
This article is still under construction. |
| Also known as: | Autonomic Polyganglioneuropathy Feline Dysautonomia |
Description
Key-Gaskell Syndrome refers to the clinical signs observed in cats with abnormal function of the sympathetic and parasympathetic nervous systems. It is similar to grass sickness in horses and, like this disease, it is often fatal.
The syndrome has occurred as outbreaks[1] in the past in the UK, continental Europe and occasionally in the USA. It was first described by Key and Gaskell as a 'puzzling syndrome' causing pupillary dilatation in cats at the start of a major outbreak in the UK in 1982[2]. It is currently described only sporadically but recent reports suggest that the incidence of the disease may be increasing again.
The cause of the dysautonomia is not known but numerous factors have been implicated and it is generally thought to occur after exposure to a toxin, possibly in dry food or vaccines. As with grass sickness, it has also been suggested that toxins produced by Clostridium botulinum may be involved in the pathogenesis of the disease and a recent study showed that cats with the disease developed significantly higher titres of IgA antibody to botulinum toxins C and D than healthy controls[3]. Whatever the cause, degenerative lesions develop in the autonomic ganglia, intermedio-lateral columns of spinal grey matter and in the axons of the sympathetic neurones.
Signalment
Historically, Key-Gaskell syndrome was reported most frequently in cats but the disease has now been shown to occur in dogs[4][5][6], particularly younger animals. There is no apparent sex predisposition but the Labrador Retriever breed may be predisposed to the development of dysautonomia.
In a recent study of 65 dogs confirmed as having dysautonomia, those raised and housed in rural environments appeared to be at greater risk (56/65 dogs) for dysautonomia than dogs from urban environments[7].
Diagnosis
Clinical Signs
The sympathetic and parasympathetic nervous systems are involved in the regulation of multiple organ systems, particularly the gastro-intestinal tract and the secretory glands. Common clinical signs therefore include:
- Anorexia and constipation due to intestinal ileus.
- Abdominal distension may occur as a result of generalised paralytic ileus.
- Megaoesophagus due to failure of oesophageal motility. This may cause regurgitation and secondary aspiration pneumonia.
- Depression
- Bradycardia
- Decreased lacrimation and salivation due to reduced tone in the parasympathetic nerves that stimulate secretion. The xerotsomia caused by reduced production of saliva may be apparent as dry mucous membranes on clinical examination.
- Pupillary dilatation due to reduced tone of the constrictor muscle of the iris, usually controlled by the parasympathetic fibres of the short ciliary nerves.
The most frequent clinical signs associated with the syndrome are depression, anorexia, constipation and regurgitation or vomiting. Incontinence (faecal and urinary) has been observed less frequently.
Diagnostic Imaging
Oesophageal dilatation may be observed on plain radiographs of the chest. A 'trachea stripe sign' may also be visible due to the compression of the tissue between the oesophagus and trachea.
Oesophageal hypomotility may be evident with barium contrast study or using fluoroscopy to observe the dynamic passage of food boluses into the stomach.
Pharmalogical Tests
Various provocative tests can be used to assess the autonomic nerbous systems of animals with suspected Key-Gaskell syndrome:
- Topical ocular administration of dilute pilocarpine should result in miosis, which implies a postive result. However, not all animals respond and the response is dependent on the degree of damage to the postganglionic parasympathetic neuron causing (denervation) supersensitivity of the iris muscle.
- Intra-venous or subcutaneous administration of atropine (a parasympatholytic) should result in an increase in the heart rate. A failure to respond implies a positive result.
- Intra-dermal administration of histamine should result in a classical wheal and flare response but this may be dampened in those animals with dysautonomia. An absence of the wheal and flare response is therefore a positive result.
Pathology
- Histologically there is marked reduction in the number of neurones in all autonomic ganglia in the ventral horn of all levels of spinal cord accompanied by proliferation of non-neuronal cells. Similar changes are found in the brainstem nuclei of the cranial nerves and features of chromatolytic degeneration may be apparent in the ganglia, spinal cord and sympathetic axons.
Differential Diagnosis
There are few differential diagnoses for this clinical presentation but, early in the course of disease, other causes of megaoesophagus should be considered.
Treatment
Supportive
Including elevated feeding, gastrostomy tube feedings or total paranteral nutrition.
Parasympathomimetic Drugs
Some dogs may show minor improvement on initiation of for example, bethanechol, metoclopramide.
Prognosis
Guarded to poor. Recovery rates in the cat are reported as 20-40%, however this may take 2-12 months. In the dog recovery rates are lower. Despite recovery many are also left with residual impairment including intermittent regurgitation.
References
- ↑ Cave TA, Knottenbelt C, Mellor DJ, Nunn F, Nart P, Reid SW Outbreak of dysautonomia (Key-Gaskell syndrome) in a closed colony of pet cats. Vet Rec. 2003 Sep 27;153(13):387-92.
- ↑ Key TJ, Gaskell CJ. Puzzling syndrome in cats associated with pupillary dilatation. Vet Rec. 1982 Feb 13;110(7):160.
- ↑ Nunn F, Cave TA, Knottenbelt C, Poxton IR. Association between Key-Gaskell syndrome and infection by Clostridium botulinum type C/D. Vet Rec. 2004 Jul 24;155(4):111-5.
- ↑ Schulze C, Schanen H, Pohlenz J. Canine dysautonomia resembling the Key-Gaskell syndrome in Germany. Vet Rec. 1997 Nov 8;141(19):496-7
- ↑ Wise LA, Lappin MR. A syndrome resembling feline dysautonomia (Key-Gaskell syndrome) in a dog. J Am Vet Med Assoc. 1991 Jun 15;198(12):2103-6.
- ↑ Rochlitz I, Bennett AM. Key-Gaskell syndrome in a bitch. Vet Rec. 1983 Jun 25;112(26):614-5.
- ↑ Harkin KR, Andrews GA, Nietfeld JC. Dysautonomia in dogs: 65 cases (1993-2000). J Am Vet Med Assoc. 2002 Mar 1;220(5):633-9.
- Hall J.H, Wimpson J. W. and Williams D.A, (2005), Disorders of the Pharynx and Oesophagus, in BSAVA Manual of Canine and Feline Gastroenterology, 2nd Edition, British Small Animal Association, Gloucester, pp 142-143
- Harkin K.R, Andrews G.A, Nietfeld J.C, (2002), Dysautonomia in dogs: 65 cases (1993–2000) J Am Vet Med Assoc, Mar 1, 220(5): pp. 633-9